Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015

BACKGROUND: The last decade was marked by major advances in HCV treatment with the introduction of first wave protease inhibitors (1st-wave PIs, telaprevir or boceprevir) in 2011 and second direct-acting antivirals (2nd-wave DAAs) in 2014, that followed low effective pegylated interferon α / ribavir...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Brouard, Cécile, Boussac-Zarebska, Marjorie, Silvain, Christine, Durand, Julien, de Lédinghen, Victor, Pillonel, Josiane, Delarocque-Astagneau, Elisabeth
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5738822/
https://ncbi.nlm.nih.gov/pubmed/29262788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2889-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados